Publications

  1. Rajput A, Ross JP, Bernales CQ, Rayaprolu S, Soto-Ortolaza AI, Ross OA, van Gerpen J, Uitti RJ, Wszolek ZK, Rajput AH, Vilarino-Guell C. VPS35 and DNAJC13 disease-causing variants in essential tremor. Eur J Hum Genet. 2014 Aug 13.
    View PubMed
  2. Shannon B, Soto-Ortolaza A, Rayaprolu S, Cannon HD, Labbe C, Benitez BA, Choi J, Lynch T, Boczarska-Jedynak M, Opala G, Krygowska-Wajs A, Barcikowska M, Van Gerpen JA, Uitti RJ, Springer W, Cruchaga C, Wszolek ZK, Ross OA. Genetic variation of the retromer subunits VPS26A/B-VPS29 in Parkinson's disease. Neurobiol Aging. 2014 Aug; 35(8):1958.e1-2. Epub 2014 Mar 05.
    View PubMed
  3. van Gerpen JA. A retrospective study of the clinical and electrophysiological characteristics of 32 patients with orthostatic myoclonus. Parkinsonism Relat Disord. 2014 Aug; 20(8):889-93. Epub 2014 May 22.
    View PubMed
  4. Vemula SR, Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Truong DD, Blitzer A, Rudzinska M, Momcilovic D, Jinnah HA, Frei K, Pfeiffer RF, LeDoux MS. A rare sequence variant in intron 1 of THAP1 is associated with primary dystonia. Mol Genet Genomic Med. 2014 May; 2(3):261-72. Epub 2014 Feb 11.
    View PubMed
  5. Ross JP, Rayaprolu S, Bernales CQ, Soto-Ortolaza AI, van Gerpen J, Uitti RJ, Wszolek ZK, Rajput A, Rajput AH, Rajput ML, Ross OA, Vilarino-Guell C. SLC1A2 rs3794087 does not associate with essential tremor. Neurobiol Aging. 2014 Apr; 35(4):935.e9-10. Epub 2013 Oct 16
    View PubMed
  6. Fujioka S, Van Gerpen JA, Uitti RJ, Dickson DW, Wszolek ZK. Familial progressive supranuclear palsy: a literature review. Neurodegener. Dis. 2014; 13(2-3):180-2.
  7. Fujioka S, Van Gerpen JA, Uitti RJ, Dickson DW, Wszolek ZK. Familial progressive supranuclear palsy: a literature review. Neurodegener Dis. 2014; 13(2-3):180-2. Epub 2013 Sep 24.
    View PubMed
  8. Ferman TJ, Smith GE, Kantarci K, Boeve BF, Pankratz VS, Dickson DW, Graff-Radford NR, Wszolek Z, Van Gerpen J, Uitti R, Pedraza O, Murray ME, Aakre J, Parisi J, Knopman DS, Petersen RC. Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies. Neurology. 2013 Dec 3; 81(23):2032-8. Epub 2013 Nov 08.
    View PubMed
  9. Sundal C, Fujioka S, Van Gerpen JA, Wider C, Nicholson AM, Baker M, Shuster EA, Aasly J, Spina S, Ghetti B, Roeber S, Garbern J, Tselis A, Swerdlow RH, Miller BB, Borjesson-Hanson A, Uitti RJ, Ross OA, Stoessl AJ, Rademakers R, Josephs KA, Dickson DW, Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations. Parkinsonism Relat Disord. 2013 Oct; 19(10):869-77. Epub 2013 Jun 17.
    View PubMed
  10. Labbe C, Soto-Ortolaza AI, Rayaprolu S, Harriott AM, Strongosky AJ, Uitti RJ, Van Gerpen JA, Wszolek ZK, Ross OA. Investigating the role of FUS exonic variants in essential tremor. Parkinsonism Relat Disord. 2013 Aug; 19(8):755-7. Epub 2013 Apr 16.
    View PubMed
  11. Dejesus-Hernandez M, Rayaprolu S, Soto-Ortolaza AI, Rutherford NJ, Heckman MG, Traynor S, Strongosky A, Graff-Radford N, Van Gerpen J, Uitti RJ, Shih JJ, Lin SC, Wszolek ZK, Rademakers R, Ross OA. Analysis of the C9orf72 repeat in Parkinson's disease, essential tremor and restless legs syndrome. Parkinsonism Relat Disord. 2013 Feb; 19(2):198-201. Epub 2012 Oct 18.
    View PubMed
  12. Van Gerpen JA, Lucas JA, Fields JA. Postsurgical behavioral changes. Milestones in Drug Therapy. 2013; 24:91-117.
  13. Khan QUA, Wharen RE, Grewal SS, Thomas CS, Deen HG Jr, Reimer R, Van Gerpen JA, Crook JE, Graff-Radford NR. Overdrainage shunt complications in idiopathic normal-pressure hydrocephalus and lumbar puncture opening pressure: Clinical article. J Neurosurg. 2013; 119(6):1498-502.
  14. Parkinson Study Group. Phase II Safety, Tolerability, and Dose Selection Study of Isradipine as a Potential Disease-Modifying Intervention in Early Parkinson’s Disease (STEADY-PD). Movement Disorders. 2013.
  15. Van Gerpen JA, Rucker CT, Matthews M, Saucier MA. Lifting the "FOG" with laser generated visual-cueing. Neurologist. 2012 Sep; 18(5):298-301.
    View PubMed
  16. Sundal C, Van Gerpen JA, Nicholson AM, Wider C, Shuster EA, Aasly J, Spina S, Ghetti B, Roeber S, Garbern J, Borjesson-Hanson A, Tselis A, Swerdlow RH, Miller BB, Fujioka S, Heckman MG, Uitti RJ, Josephs KA, Baker M, Andersen O, Rademakers R, Dickson DW, MRI characteristics and scoring in HDLS due to CSF1R gene mutations. Neurology. 2012 Aug 7; 79(6):566-74. Epub 2012 Jul 25.
    View PubMed
  17. LeDoux MS, Xiao J, Rudzinska M, Bastian RW, Wszolek ZK, Van Gerpen JA, Puschmann A, Momcilovic D, Vemula SR, Zhao Y. Genotype-phenotype correlations in THAP1 dystonia: molecular foundations and description of new cases. Parkinsonism Relat Disord. 2012 Jun; 18(5):414-25. Epub 2012 Feb 28.
    View PubMed
  18. Rademakers R, Baker M, Nicholson AM, Rutherford NJ, Finch N, Soto-Ortolaza A, Lash J, Wider C, Wojtas A, DeJesus-Hernandez M, Adamson J, Kouri N, Sundal C, Shuster EA, Aasly J, MacKenzie J, Roeber S, Kretzschmar HA, Boeve BF, Knopman DS, Petersen RC, Cair Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nat Genet. 2012 Feb; 44(2):200-5. Epub 2011 Dec 25
    View PubMed
  19. Wray S, Self M, NINDS Parkinson's Disease iPSC Consortium, NINDS Huntington's Disease iPSC Consortium, NINDS ALS iPSC Consortium, Lewis PA, Taanman JW, Ryan NS, Mahoney CJ, Liang Y, Devine MJ, Sheerin UM, Houlden H, Morris HR, Healy D, Marti-Masso JF, Creation of an open-access, mutation-defined fibroblast resource for neurological disease research. PLoS One. 2012; 7(8):e43099. Epub 2012 Aug 27.
    View PubMed
  20. Freeman WD, Dorsher PT, Safford RE, Van Gerpen J, Edwards WD. Combined pergolide-associated valvular heart disease and achilles tendon contractures. Acta Med Acad. 2012; 41(2):228-30.
    View PubMed
  21. Ferman TJ, Boeve BF, Smith GE, Lin SC, Silber MH, Pedraza O, Wszolek Z, Graff-Radford NR, Uitti R, Van Gerpen J, Pao W, Knopman D, Pankratz VS, Kantarci K, Boot B, Parisi JE, Dugger BN, Fujishiro H, Petersen RC, Dickson DW. Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies. Neurology. 2011 Aug 30; 77(9):875-82. Epub 2011 Aug 17.
    View PubMed
  22. Ross OA, Rutherford NJ, Baker M, Soto-Ortolaza AI, Carrasquillo MM, DeJesus-Hernandez M, Adamson J, Li M, Volkening K, Finger E, Seeley WW, Hatanpaa KJ, Lomen-Hoerth C, Kertesz A, Bigio EH, Lippa C, Woodruff BK, Knopman DS, White CL 3rd, Van Gerpen JA, Ataxin-2 repeat-length variation and neurodegeneration. Hum Mol Genet. 2011 Aug 15; 20(16):3207-12. Epub 2011 May 24.
    View PubMed
  23. Elbaz A, Ross OA, Ioannidis JP, Soto-Ortolaza AI, Moisan F, Aasly J, Annesi G, Bozi M, Brighina L, Chartier-Harlin MC, Destee A, Ferrarese C, Ferraris A, Gibson JM, Gispert S, Hadjigeorgiou GM, Jasinska-Myga B, Klein C, Kruger R, Lambert JC, Lohmann K, Independent and joint effects of the MAPT and SNCA genes in Parkinson disease. Ann Neurol. 2011 May; 69(5):778-92. Epub 2011 Mar 09.
    View PubMed
  24. Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Simon DK, Tarsy D, Hedera P, Truong DD, Frei KP, Blitzer A, Rudzinska M, Pfeiffer RF, Le C, LeDoux MS. The c.-237_236GA>TT THAP1 sequence variant does not increase risk for primary dystonia. Mov Disord. 2011 Feb 15; 26(3):549-52. Epub 2011 Mar 02.
    View PubMed
  25. Van Gerpen JA. Office assessment of gait and station. Semin Neurol. 2011 Feb; 31(1):78-84. Epub 2011 Feb 14.
    View PubMed
  26. Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Simon DK, Tarsy D, Hedera P, Truong DD, Frei KP, Dev Batish S, Blitzer A, Pfeiffer RF, Gong S, LeDoux MS. Novel THAP1 sequence variants in primary dystonia. Neurology. 2010 Jan 19; 74(3):229-38.
    View PubMed
  27. Shih JJ, LeslieMazwi T, Falcao G, Van Gerpen J. Directed aggressive behavior in frontal lobe epilepsy: a video-EEG and ictal spect case study. Neurology. 2009 Nov 24; 73(21):1804-6. Epub 2009 Oct 21.
    View PubMed
  28. Wider C, Van Gerpen JA, DeArmond S, Shuster EA, Dickson DW, Wszolek ZK. Leukoencephalopathy with spheroids (HDLS) and pigmentary leukodystrophy (POLD): a single entity? Neurology. 2009 Jun 2; 72(22):1953-9.
    View PubMed
  29. Van Gerpen JA, Wider C, Broderick DF, Dickson DW, Brown LA, Wszolek ZK. Insights into the dynamics of hereditary diffuse leukoencephalopathy with axonal spheroids. Neurology. 2008 Sep 16; 71(12):925-9.
    View PubMed
  30. Gros AJ Jr, Thomas LC, McKinley KL, Van Gerpen JA. Prevention of an acute severe exacerbation of Stiff-person syndrome during surgery. Anesthesiology. 2006 Apr; 104(4):885-6.
    View PubMed
  31. Van Gerpen JA, Kumar N, Bower JH, Weigand S, Ahlskog JE. Levodopa-associated dyskinesia risk among Parkinson disease patients in Olmsted County, Minnesota, 1976-1990. Arch Neurol. 2006 Feb; 63(2):205-9.
    View PubMed
  32. Van Gerpen JA. Dopa-responsive dystonic camptocormia. Neurology. 2006; 66:1779.
  33. Van Gerpen JA. A Review of The Parkinson’s Disease Treatment Book by Dr.J Eric Ahlskog Oxford University Press, 2005 Mayo Clin Proc. 2006.
  34. Kumar N, Van Gerpen JA, Bower JH, Ahlskog JE. Levodopa-dyskinesia incidence by age of Parkinson's disease onset. Mov Disord. 2005 Mar; 20(3):342-4.
    View PubMed
  35. Van Gerpen JA, Caruso S. Tick paralysis. Mayo Clin Proc. 2005; 80:938.
  36. Van Gerpen JA, Ahlskog JE, Petty GW. Progressive supranuclear palsy phenotype secondary to CADASIL. Parkinsonism & Related Disorders. 2003 Aug; 9(6):367-9.
    View PubMed
  37. Sejvar JJ, Haddad MB, Tierney BC, Campbell GL, Marfin AA, Van Gerpen JA, Fleischauer A, Leis AA, Stokic DS, Petersen LR. Neurologic manifestations and outcome of West Nile virus infection. JAMA. 2003 Jul 23; 290(4):511-5.
    View PubMed
  38. Josephs KA, Van Gerpen MW, Van Gerpen JA. Adult onset Niemann-Pick disease type C presenting with psychosis. J Neurol Neurosurg Psychiatry. 2003 Apr; 74(4):528-9.
    View PubMed
  39. Van Gerpen JA, Dyck PJB, Dyck PJ. Cutaneous T-Cell lymphoma imitating gelsolin amyloidosis. Neurology. 2003; 60:861.
  40. Sejvar JJ, Leis A, Stovic DS, Van Gerpen JA, et al. Acute flaccid paralysis associated with West Nile virus infection. J Emerg Infect Dis. 2003; 9:788-93.
  41. Van Gerpen JA. Neurologic sequelae of West Nile virus infection. Ochsner Journal. 2003; 5:18-20.
  42. Elbaz A, Peterson BJ, Yang P, Van Gerpen JA, Bower JH, Maraganore DM, McDonnell SK, Ahlskog JE, Rocca WA. Nonfatal cancer preceding Parkinson's disease: a case-control study. Epidemiology. 2002 Mar; 13(2):157-64.
    View PubMed
  43. Sejvar JJ, Leis A, Van Gerpen JA, et al. Acute flaccid paralysis syndrome associated with west nile virus infection -- Mississippi and Louisiana, July-August 2002. MMWR. 2002; 51:825-8.
  44. Van Gerpen JA. Drug-induced parkinsonism. Neurolog. 2002; 8:363-70.
  45. Van Gerpen JA. Camptocormia secondary to early amyotrophic lateral sclerosis. Mov Disord. 2001 Mar; 16(2):358-60.
    View PubMed
  46. Van Gerpen JA, Goudreau JL, Dodick DW, Gertz MA. Amyloidosis presenting with intractable epistaxis and multiple cranial neuropathies. Neurology. 2000 Dec 12; 55(11):1755-6.
    View PubMed
  47. Van Gerpen JA, Matsumoto JY, Ahlskog JE, Maraganore DM, McManis PG. Utility of an EMG mapping study in treating cervical dystonia. Muscle Nerve. 2000 Nov; 23(11):1752-6.
    View PubMed
  48. Van Gerpen JA, Hickey S, Capobianco DJ. Migraine: Diagnosis, prevention and treatment. Jacksonville Medicine. 2000; 51(4):156-62.
  49. Van Gerpen JA, Kelly M, Fort DW. Multiple cranial neuropathies: unusual presentation of acute T-cell lymphoma. J Child Neurol. 1998 Apr; 13(4):185-7.
    View PubMed
  50. Van Gerpen JA. Tremor caused by trimethoprim-sulfamethoxazole in a patient with AIDS. Neurology. 1997 Feb; 48(2):537-8.
    View PubMed